![]() ![]() Morgan Stanley, BofA Securities, CICC, Tiger Brokers, and Snowball Securities were set to be the joint bookrunners on the deal. Sources Didi Chinabased Hold Linkdoc Us by deepika Mantis Vision is planning to double its world workforce with a further 100 forty workers in Israel, U.S., China and Slovak Republic by the top of 2020. It had planned to list on the Nasdaq under the symbol LDOC. /rebates/&252fchinabased-keep-linkdoc-us-ipotimes. The Beijing, China-based company was founded in 2014 and booked $154 million in sales for the 12 months ended March 31, 2021. The company's product suite includes a digital continuous care platform for patients with critical diseases, an AI-enabled curation system for longitudinal medical data, and a precision life sciences platform for clinical research. So far this year, 31 Chinese issuers have raised $12.3 billion in US IPOs, more than all of last year, representing roughly 15% of the US IPO market by deal count and proceeds.īacked by Alibaba Health, LinkDoc Technology provides a platform that structures cancer patient data to enable precision medicine and personalized care. According to anonymously-sourced whispers, LinkDoc, a provider of cancer-focused health care services using big data and artificial intelligence, had planned to sell 10.8MM shares priced between 17.50 and. Days after DiDi Global's (DIDI) $4.4 billion US IPO, the regulator announced that it was pulling DiDi's app from the app store until it came under compliance with certain data security requirements, causing the stock to crash. On Wednesday, LinkDoc updated its prospectus to cite new risks from Beijing, in what was perhaps a hint that the deal would soon be pulled. The news comes amid China's latest crackdown of its domestic internet companies, which has most recently focused on US listings. On Wednesday, LinkDoc filed an amendment where it added risks related to China's new capital markets regulation and oversight, which had been issued by the country's regulator the day before. ![]() It had filed to raise $200 million by offering 10.8 million shares at a price range of $17.50 to $19.50. Insiders and anchor investors had indicated an interest in buying 58% of the deal. The company had been expected to price its IPO on Thursday night. LinkDoc collects and standardizes healthcare data, covering more than 3,000 diseases, from hospitals and provides customized data for healthcare regulators. LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, postponed its IPO on Thursday. Also, the company admitted that its main source of revenue relies on a small number of key clients. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |